Antares Pharma, Inc. (AIS) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts AIS Hot Sheet
Price: $68.07 +0.37%
Financial Fact:
Licensing revenue: 38.62K
Today's EPS Names:
RIBT, INLB, FTXP, More
Financial Fact:
Licensing revenue: 38.62K
Today's EPS Names:
RIBT, INLB, FTXP, More
Join SI Premium – FREE
Antares Pharma, Inc. (NYSE: AIS) reported Q4 EPS of $0.00, in-line with the analyst estimate of $0.00. Revenue for the quarter came in at $5.4 million versus the consensus estimate of $4.88 million.
For earnings history and earnings-related data on Antares Pharma, Inc. (AIS) click here.
For earnings history and earnings-related data on Antares Pharma, Inc. (AIS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E downgraded by Wells Fargo, BMO as California wildfire reform falls short
- BofA turns S&P 500 signals from red to yellow: What to buy now
- Celanese to sell 19% Nutrinova stake to Mitsui for $152 million
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
